TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biobasiq Sverige AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
26,402
|
18,054
|
16,087 |
Financial expenses |
45
|
58
|
78 |
Earnings before taxes |
73
|
1,059
|
1,762 |
EBITDA |
66
|
1,118
|
1,840 |
Total assets |
7,901
|
7,358
|
6,015 |
Current assets |
7,901
|
7,358
|
6,015 |
Current liabilities |
2,549
|
2,060
|
1,557 |
Equity capital |
5,352
|
5,298
|
4,458 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
67.7%
|
72.0%
|
74.1% |
Turnover per employee |
13,201
|
9,027
|
8,044 |
Profit as a percentage of turnover |
0.3%
|
5.9%
|
11.0% |
Return on assets (ROA) |
1.5%
|
15.2%
|
30.6% |
Current ratio |
310.0%
|
357.2%
|
386.3% |
Return on equity (ROE) |
1.4%
|
20.0%
|
39.5% |
Change turnover |
8,348
|
1,967
|
1,757 |
Change turnover % |
46%
|
12%
![]() |
12% |
Chg. No. of employees |
0
![]() |
0
|
-1 |
Chg. No. of employees % |
0%
![]() |
0%
|
-33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.